| Property | Value |
|
first name
|
Steven
|
|
full name
|
Steven White
|
|
label
|
White, Steven
|
|
overview
|
Dr. White brings over 30 years of experience in the study of asthma, airway inflammation, and airway remodeling, with a long-standing focus on understanding the mechanisms behind persistent inflammation and aberrant tissue repair in the lungs. In recent years, Dr. White’s research has increasingly concentrated on the initial cellular response to airway injury, integrating cell biology approaches to uncover early drivers of disease progression. Parallel to this work, Dr. White has also prioritized investigating clinical parameters that are essential to improving the care and outcomes of patients with asthma.
Dr. White has successfully led several major NIH-funded research projects, all requiring extensive interdisciplinary collaboration and resulting in numerous peer-reviewed publications in leading biomedical journals. As the contact Principal Investigator for a U19-funded Asthma and Allergic Diseases Cooperative Research Center supported by the National Institute of Allergy and Infectious Diseases (NIAID), Dr. White helped establish a robust research platform for understanding severe asthma. Most recently, this work has evolved into the UG1-funded PrecISE (Precision Interventions for Severe and/or Exacerbation-Prone Asthma) protocol, a precision medicine initiative aimed at advancing treatment strategies for high-risk asthma populations.
In addition to research, Dr. White co-directs a comprehensive, hospital-wide COPD clinical program focused on reducing readmissions and improving care transitions from inpatient to outpatient and community-based medicine. This multidisciplinary effort has already achieved significant reductions in readmission rates, and Dr. White oversees the clinical support team responsible for direct patient care.
Dr. White’s program also leads innovative work on the role of the airway epithelium in host defense responses to the airway microbiome. The team currently manages the largest single-center study examining the respiratory microbiome, with a particular emphasis on understanding the interaction between the fungal microbiome (the mycobiome) and the bacterial microbiome in asthma.
Through all of these endeavors, Dr. White remains dedicated to the belief that advancing both basic and translational lung science will drive the development of more effective therapies for asthma and related pulmonary diseases.
|